CBPO [China Biologic Products] SC 13D: JOINT FILING AGREEMENT [Remainder of Page Intentionally Left

[JOINT FILING AGREEMENT [Remainder of Page Intentionally Left Blank] GL Trade Investment Limited Hu Chou Hui Director GL China Opportunities Fund L.P. Zhenfu Li Authorized Signatory GL Capital Management GP L.P. Zhenfu Li Authorized Signatory GL Capital Management GP Limited Zhenfu Li Director GL Par]

VNET [21Vianet] 6-K: (Original Filing)

[21Vianet Group, Inc. Reports Unaudited Second Quarter 2018 Financial Results Adjusted EBITDA up 103.6% YoY to RMB221.1 million Adjusted EBITDA margin expanded to 26.7% Raised full year guidance for both net revenues and adjusted EBITDA Dial-in BEIJING, August 17, 2018 (GLOBE NEWSWIRE) — 21Vianet Gro]

CBPO [China Biologic Products] SC 13D: PROPOSAL LETTER August 17, 2018 The Board of

[PROPOSAL LETTER August 17, 2018 The Board of Directors China Biologic Products Holdings, Inc. 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China Dear Members of the Board of Directors: Mr. Gao GL Capital BOCGI CDH Consortium ]

VNET [21Vianet] 6-K: 21Vianet Group, Inc. Reports Unaudited Second Quarter 2018

[21Vianet Group, Inc. Reports Unaudited Second Quarter 2018 Financial Results Adjusted EBITDA up 103.6% YoY to RMB221.1 million Adjusted EBITDA margin expanded to 26.7% Raised full year guidance for both net revenues and adjusted EBITDA Dial-in BEIJING, August 17, 2018 (GLOBE NEWSWIRE) — 21Vianet Gro]

XNY [China Xiniya Fashion] 6-K: (Original Filing)

[Dunxin Financial Holdings Limited Reports Financial Results for the First Six Months of 2018 WUHAN, HUBEI, China—August 20, 2018—Dunxin Financial Holdings Limited (“Dunxin” or the “Company”) (NYSE American: DXF), a leading licensed microfinance lender serving individuals and small and medium enterpr]

Skip to toolbar